Pages that link to "Q28610996"
Jump to navigation
Jump to search
The following pages link to Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 (Q28610996):
Displaying 50 items.
- Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase (Q24318419) (← links)
- Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex (Q24336071) (← links)
- Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement (Q24529520) (← links)
- Complement in age-related macular degeneration: a focus on function (Q24635874) (← links)
- Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice (Q24651118) (← links)
- The pathogenesis of hyaline arteriolosclerosis (Q24676062) (← links)
- AMD and the alternative complement pathway: genetics and functional implications (Q26744106) (← links)
- Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway (Q26768534) (← links)
- The complotype: dictating risk for inflammation and infection (Q26862665) (← links)
- Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement (Q27653668) (← links)
- Solution Structure of CCP Modules 10–12 Illuminates Functional Architecture of the Complement Regulator, Factor H (Q27673696) (← links)
- Complement C3b interactions studied with surface plasmon resonance technique (Q28189958) (← links)
- Structure of C3b in complex with CRIg gives insights into regulation of complement activation (Q28269302) (← links)
- Structures of complement component C3 provide insights into the function and evolution of immunity (Q28273530) (← links)
- Ovariectomy and subsequent treatment with estrogen receptor agonists tune the innate immune system of the hippocampus in middle-aged female rats (Q28573502) (← links)
- Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products (Q28610971) (← links)
- Complement: a key system for immune surveillance and homeostasis (Q29615484) (← links)
- A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors (Q30409539) (← links)
- C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles (Q30899864) (← links)
- Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome (Q33384039) (← links)
- Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome (Q33419905) (← links)
- Post-bone marrow transplant thrombotic microangiopathy (Q33430697) (← links)
- HUS and atypical HUS. (Q33441069) (← links)
- Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H (Q33749851) (← links)
- Spatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substance (Q33894669) (← links)
- Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. (Q33925578) (← links)
- Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. (Q34122609) (← links)
- Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury (Q34162118) (← links)
- The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice (Q34297184) (← links)
- Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces. (Q34452451) (← links)
- Complement System Part I - Molecular Mechanisms of Activation and Regulation (Q34481071) (← links)
- Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. (Q34548269) (← links)
- Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury (Q34572148) (← links)
- The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. (Q35097528) (← links)
- Possible steps required in the internalization of nude Epstein—Barr virus (Q35114227) (← links)
- Serum bicarbonate levels and the progression of kidney disease: a cohort study (Q35163009) (← links)
- Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep (Q35186726) (← links)
- Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans (Q35187024) (← links)
- The role of complement in tumor growth (Q35231345) (← links)
- Functional characterization of a ficolin-mediated complement pathway in amphioxus (Q35378806) (← links)
- Structural transitions of complement component C3 and its activation products (Q35544520) (← links)
- A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H (Q35809292) (← links)
- Quantitative Modeling of the Alternative Pathway of the Complement System (Q35975481) (← links)
- Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of β1H and is accompanied by generation of C3c (Q36308579) (← links)
- Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles. (Q36323504) (← links)
- Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin (Q36348883) (← links)
- Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). (Q36366046) (← links)
- Complement activation, regulation, and molecular basis for complement-related diseases (Q36380682) (← links)
- The role of complement in danger sensing and transmission (Q36499763) (← links)
- Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement. (Q36540594) (← links)